期刊文献+

p21基因转染人肝癌SMMC-7721细胞对化疗药物敏感性的研究 被引量:1

Study on sensitivity of human SMMC-7721 liver cancer cells transfected with p21 gene to chemotherapeutic drugs
暂未订购
导出
摘要 目的探讨p21基因转染人肝癌SMMC-7721细胞(7721细胞)对化疗药物的敏感性,深入研究p21基因对肝癌细胞的治疗作用。方法应用磷酸钙介导p21基因转染人肝癌7721细胞;通过G418筛选稳定表达细胞株并扩大培养;采用MTT法检测肿瘤细胞增殖速度;流式细胞术检测细胞周期变化。结果经过3~4w G418筛选得到稳定表达的细胞株,p21基因稳定转染并联合化疗药物应用可明显抑制7721细胞的体外增殖,细胞周期明显改变,细胞从G1期到G2期发生阻滞。结论提示转染外源p21基因联合化疗药物可使7721细胞周期阻滞于G1期,并可抑制肿瘤细胞增殖。 Objective To explore the sensitivity of the human liver cancer cells transfected with p21 gene to chemotherapeutic drugs, and further understand the mechanism of the tumor suppressor gene p21. Methods The p21 gene induced by calcium phosphate was transfected into human liver cancer cell line (7721). The stable expression cells were selected by G418. The proliferation of tumor cells was examined by MTT assay, and the changes of cell cycle progression were observed by flow cytometry (FCM). Results The stable expression cells were obtained after selected by G418 for 3 -4 w. Proliferation of 7721 was inhibited significantly by stable p21 gene transfected and chemotherapeutic drugs in vitro. The progression of cell cycle was arrested from G1 to G2 phase. Conclusions The growth of 7721 cell could be arrested at G1 phase, and it could be significantly suppressed by exogenous p21 gene transfected and chemotherapeutic drugs.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2006年第9期1221-1223,共3页 Chinese Journal of Gerontology
关键词 P21基因 肝癌细胞株 MTT法 基因转染 p21 gene Hepatocellular carcinoma cell line MTr assay Gene transfectio n
  • 相关文献

参考文献6

二级参考文献22

共引文献191

同被引文献11

  • 1张汝,顾军,张涛,姚斌,李刚,罗锋,陈芳.p53 p16与进展期NSCLC化疗的关系[J].西南国防医药,2005,15(2):141-143. 被引量:1
  • 2李倩玉,王一,王涛,吴孟超.9种耐药相关蛋白在肝癌中的表达及其临床意义[J].中华实验外科杂志,2006,23(3):282-283. 被引量:13
  • 3黄美兰,冉志华,萧树东.人结肠癌组织中肿瘤耐药相关基因的表达及其临床意义[J].胃肠病学,2006,11(5):263-267. 被引量:2
  • 4李倩玉,王一,殷正丰,吴孟超.优化的MTT比色法在肝癌天然耐药预测中的应用[J].中华医学杂志,2007,87(5):333-335. 被引量:4
  • 5Wang Y,Wu MC,Sham JST,et al.Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue,studied using a tissue microarray[J].J Path,2002,197(5):610-616.
  • 6Petty WJ,Dragnev KH,Dmitrovsky E.Cyclin D1 as a target for chemoprevention[J].Lung Cancer,2003,41 (Suppl 1):S155-161.
  • 7Drobnjak M,Osman I,Scher HI,et al.Overexpression of Cyclin D1 is associated with metastatic prostate cancer to bone[J].Clin Cancer Res,2000,6(5):1891-1895.
  • 8Butt AJ,Caldon CE,McNeil CM,et al.Cell cycle machinery:links with genesis and treatment of breast cancer[J].Adv Exp Med Biol,2008,630:189-205.
  • 9Smalley KS,Lioni M,Dalla Palma M,et al.Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas[J].Mol Cancer Ther,2008,7 (9):2876-2883.
  • 10Lau CK,Yang ZF,Lam SP,et al.Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma[J].Cancer Biol Ther,2007,6(12):1900-1907.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部